MedTrace Logo

Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma

NCT04619654 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2022-11-08

No results posted yet for this study

Summary

This study will examine the visual outcomes of subjects undergoing cataract surgery and minimally invasive glaucoma surgery with the implantation of a trifocal intraocular lens.

Conditions

  • Cataract
  • IOL
  • Glaucoma, Open-Angle

Interventions

PROCEDURE

Cataract surgery with implantation of trifocal IOL combined with trabecular scaffold

Cataract surgery with implantation of the PanOptix IOL combined with minimally invasive glaucoma surgery utilizing the Hydrus Microstent

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Vold Vision P.L.L.C

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-06-01
Completion
2022-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04619654 on ClinicalTrials.gov